39 related articles for article (PubMed ID: 32641280)
1. The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.
Kim K; Kim JH; Park IS; Rho YS; Kwon GH; Lee DJ
World J Surg; 2018 Nov; 42(11):3624-3631. PubMed ID: 29750323
[TBL] [Abstract][Full Text] [Related]
2. Chromatin accessibility associates with protein-RNA correlation in human cancer.
Sanghi A; Gruber JJ; Metwally A; Jiang L; Reynolds W; Sunwoo J; Orloff L; Chang HY; Kasowski M; Snyder MP
Nat Commun; 2021 Sep; 12(1):5732. PubMed ID: 34593797
[TBL] [Abstract][Full Text] [Related]
3. Editorial: Recent advances in papillary thyroid carcinoma: diagnosis and predictive factors.
Volpi EM; Ramirez-Ortega MC; Carrillo JF
Front Endocrinol (Lausanne); 2023; 14():1283397. PubMed ID: 37786792
[No Abstract] [Full Text] [Related]
4. Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects.
Landa I; Thornton CEM; Xu B; Haase J; Krishnamoorthy GP; Hao J; Knauf JA; Herbert ZT; MartÃnez P; Blasco MA; Ghossein R; Fagin JA
Mol Cancer Res; 2023 Nov; 21(11):1163-1175. PubMed ID: 37478162
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of thyroid neoplasm using support vector machine algorithms based on platelet RNA-seq.
Shen Y; Lai Y; Xu D; Xu L; Song L; Zhou J; Song C; Wang J
Endocrine; 2021 Jun; 72(3):758-783. PubMed ID: 33179221
[TBL] [Abstract][Full Text] [Related]
6. Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer.
Qu H; Zhang Z; Zhang D; Okamoto T; Zhang P; Zhang H; Dong W
Thyroid; 2023 Oct; 33(10):1264-1267. PubMed ID: 36974364
[No Abstract] [Full Text] [Related]
7. Predicting the Aggressiveness of Papillary Thyroid Carcinoma Preoperatively: Early Steps in the Right Direction.
Broder JS
Acad Radiol; 2024 Feb; 31(2):536-537. PubMed ID: 38000923
[No Abstract] [Full Text] [Related]
8. Immune Landscape of Thyroid Cancers: New Insights.
Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
[TBL] [Abstract][Full Text] [Related]
9. Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma.
Potter SL; Reuther J; Chandramohan R; Gandhi I; Hollingsworth F; Sayeed H; Voicu H; Kakkar N; Baksi KS; Sarabia SF; Lopez ME; Chelius DC; Athanassaki ID; Mahajan P; Venkatramani R; Quintanilla NM; Lopez-Terrada DH; Roy A; Parsons DW
Pediatr Blood Cancer; 2021 Jan; 68(1):e28741. PubMed ID: 33009870
[TBL] [Abstract][Full Text] [Related]
10. The expression level of chicken telomerase reverse transcriptase in tumors induced by ALV-J is positively correlated with methylation and mutation of its promoter region.
Xiang Y; Chen Q; Li Q; Liang C; Cao W
Vet Res; 2022 Jun; 53(1):49. PubMed ID: 35739589
[TBL] [Abstract][Full Text] [Related]
11. A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma.
Yang Y; Hua W; Zeng M; Yu L; Zhang B; Wen L
Open Med (Wars); 2022; 17(1):22-33. PubMed ID: 34950770
[TBL] [Abstract][Full Text] [Related]
12. Prospective Analysis of
Choi YS; Choi SW; Yi JW
J Clin Med; 2021 May; 10(10):. PubMed ID: 34070093
[TBL] [Abstract][Full Text] [Related]
13.
Tanaka A; Matsuse M; Saenko V; Nakao T; Yamanouchi K; Sakimura C; Yano H; Nishihara E; Hirokawa M; Suzuki K; Miyauchi A; Eguchi S; Yoshiura KI; Yamashita S; Nagayasu T; Mitsutake N
Thyroid; 2019 Aug; 29(8):1105-1114. PubMed ID: 31286848
[No Abstract] [Full Text] [Related]
14. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Bu R; Siraj AK; Divya SP; Kong Y; Parvathareddy SK; Al-Rasheed M; Al-Obaisi KAS; Victoria IG; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
Int J Cancer; 2018 May; 142(10):2028-2039. PubMed ID: 29266240
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
Chien MN; Yang PS; Hsu YC; Liu TP; Lee JJ; Cheng SP
Head Neck; 2018 Nov; 40(11):2528-2537. PubMed ID: 30102829
[TBL] [Abstract][Full Text] [Related]
16. A Clinical Overview of Telomerase-Associated Aberrancies in Follicular Thyroid Tumors as Diagnostic and Prognostic Markers: Tert Alert!
Juhlin CC
Scand J Surg; 2020 Sep; 109(3):187-192. PubMed ID: 31131695
[TBL] [Abstract][Full Text] [Related]
17. Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review.
Lee YS; Kim Y; Jeon S; Bae JS; Jung SL; Jung CK
Int J Clin Exp Pathol; 2015; 8(7):7988-97. PubMed ID: 26339365
[TBL] [Abstract][Full Text] [Related]
18. Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.
Kwon JH; Yi JW
Surgery; 2021 Jan; 169(1):43-49. PubMed ID: 32641280
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
